Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Influenza antibody response following aerosal administration of inactivated virus.

× No keyword cloud information.

11 in total

1. Anti-reticulin antibody in jejunal juice in coeliac disease.

Authors: H Mawhinney; A H Love
Journal: Clin Exp Immunol Date: 1975-09 Impact factor: 4.330

2. IgA polymerization contributes to efficient virus neutralization on human upper respiratory mucosa after intranasal inactivated influenza vaccine administration.

Authors: Yoshihiko Terauchi; Kaori Sano; Akira Ainai; Shinji Saito; Yuki Taga; Kiyoko Ogawa-Goto; Shin-Ichi Tamura; Takato Odagiri; Masato Tashiro; Mikiya Fujieda; Tadaki Suzuki; Hideki Hasegawa
Journal: Hum Vaccin Immunother Date: 2018-04-09 Impact factor: 3.452

Review 3. Microneedle and mucosal delivery of influenza vaccines.

Authors: Sang-Moo Kang; Jae-Min Song; Yeu-Chun Kim
Journal: Expert Rev Vaccines Date: 2012-05 Impact factor: 5.217

4. Age-dependent antibody response in mice and humans following oral influenza immunization.

Authors: R H Waldman; K C Bergmann; J Stone; S Howard; V Chiodo; A Jacknowitz; E R Waldman; R Khakoo
Journal: J Clin Immunol Date: 1987-07 Impact factor: 8.317

5. Immunoglobulin classes of antibodies in milk of swine after intranasal exposure to pseudorabies virus or transmissible gastroenteritis virus.

Authors: L F Saif; E H Bohl
Journal: Infect Immun Date: 1977-06 Impact factor: 3.441

6. Neutralising antibody against type 1 and type 2 herpes simplex virus in cervical mucus of women with cervical intra-epithelial neoplasia.

Authors: J F Murphy; D F Murphy; S Barker; M L Mylotte; B M Coughlan; G R Skinner
Journal: Med Microbiol Immunol Date: 1985 Impact factor: 3.402

7. Intranasal immunization of mice with influenza vaccine in combination with the adjuvant LT-R72 induces potent mucosal and serum immunity which is stronger than that with traditional intramuscular immunization.

Authors: J D Barackman; G Ott; D T O'Hagan
Journal: Infect Immun Date: 1999-08 Impact factor: 3.441

8. A safety evaluation of DAS181, a sialidase fusion protein, in rodents.

Authors: Jeffrey L Larson; Seong-Kwi Kang; Bo In Choi; Maria Hedlund; Laura M Aschenbrenner; Beth Cecil; Gloriamay Machado; Matthew Nieder; Fang Fang
Journal: Toxicol Sci Date: 2011-05-13 Impact factor: 4.849

9. Pandemic influenza vaccines - the challenges.

Authors: Lars R Haaheim; Abdullah S Madhun; Rebecca Cox
Journal: Viruses Date: 2009-12-03 Impact factor: 5.048

10. Prolonged protection against Intranasal challenge with influenza virus following systemic immunization or combinations of mucosal and systemic immunizations with a heat-labile toxin mutant.

Authors: Fengmin Zhou; Amanda Goodsell; Yasushi Uematsu; Michael Vajdy
Journal: Clin Vaccine Immunol Date: 2009-02-04